The Discovery of Novel 10,11-Dihydro-5H-dibenz[b,f]azepine SIRT2 Inhibitors. (2012)
Attributed to:
Validation of the Commercial Potential of a Novel in silico Approach for Drug Discovery and Development
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1039/c2md00290f
PubMed Identifier: 24340169
Publication URI: http://europepmc.org/abstract/MED/24340169
Type: Journal Article/Review
Parent Publication: MedChemComm
Issue: 3
ISSN: 2040-2503